Morphosys (MOR) has released an update.
MorphoSys AG has announced a change in major holdings, revealing that Morgan Stanley now possesses a combined total of 11.58% of the company’s voting rights after crossing the threshold on April 12, 2024. This change reflects an adjustment in both share ownership and financial instruments, with Morgan Stanley & Co. LLC holding a direct 5.63% in voting rights.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
